Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 23,760	$ 20,331
Restricted cash	300	300
Accounts receivable, net of allowance for credit losses of $691 and $653, respectively	28,578	12,136
Inventory	14,528	10,523
Prepaid expenses and other current assets	4,472	2,823
Total current assets	71,638	46,113
Property and equipment, net	290	102
Right of use assets, net	82	138
Intangible assets, net	1,216	975
Other assets	1,639	2,187
Total assets	74,865	49,515
Current liabilities:
Accounts payable	17,656	11,281
Accrued and other expenses	21,140	16,378
Current portion of deferred revenues	2,120	1,404
Line of credit	18,616	6,263
Current portion of long-term and other debt	3,406	1,103
Total current liabilities	62,938	36,429
Long-term debt, net	2,925	4,331
Common stock warrant liabilities	47,386	25,343
Other long-term liabilities	215	226
Total liabilities	113,464	66,329
Commitments and Contingencies
Mezzanine equity:
Mezzanine equity	15,544	12,937
Stockholders’ deficit:
Common stock, $0.0001 par value, 107,142,857 shares authorized as of September 30, 2025 and December 31, 2024; 16,502,152 and 15,725,783 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively	2	2
Additional paid-in capital	244,538	238,442
Accumulated deficit	(298,683)	(268,195)
Total stockholders’ deficit	(54,143)	(29,751)
Total liabilities, mezzanine equity, and stockholders' deficit	74,865	49,515
Series A Convertible Preferred Stock
Mezzanine equity:
Mezzanine equity	6,651	5,151
Series B Convertible Preferred Stock
Mezzanine equity:
Mezzanine equity	4,496	3,452
Redeemable Common Stock
Mezzanine equity:
Mezzanine equity	$ 4,397	$ 4,334